Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and …
…, E Ferrannini, J Halcox, W Kiowski… - Journal of …, 2005 - journals.lww.com
Dysfunction of the vascular endothelium is a hallmark of most conditions that are associated
with atherosclerosis and is therefore held to be an early feature in atherogenesis. However, …
with atherosclerosis and is therefore held to be an early feature in atherogenesis. However, …
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension …
…, S Erdine, K Narkiewicz, W Kiowski… - European heart …, 2007 - academic.oup.com
Recommendations about therapy for hypertension are here preceded by some considerations
on the strength of available evidence on the benefits associated with antihypertensive …
on the strength of available evidence on the benefits associated with antihypertensive …
[HTML][HTML] Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
…, H Haller, A Heagerty, SE Kjeldsen, W Kiowski… - Blood …, 2009 - Taylor & Francis
GIUSEPPE MANCIAa, STÉPHANE LAURENTb, ENRICO AGABITI-ROSEIc, ETTORE
AMBROSIONId, MICHEL BURNIERe, MARK J. CAULFIELDf, RENATA CIFKOVAg, DENIS …
AMBROSIONId, MICHEL BURNIERe, MARK J. CAULFIELDf, RENATA CIFKOVAg, DENIS …
Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the …
M Packer, JJV McMurray, H Krum, W Kiowski… - JACC: Heart Failure, 2017 - jacc.org
Objectives : The objective of this clinical trial was to evaluate the long-term effect of endothelin
receptor antagonism with bosentan on the morbidity and mortality of patients with severe …
receptor antagonism with bosentan on the morbidity and mortality of patients with severe …
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.
L Linder, W Kiowski, FR Bühler, TF Lüscher - Circulation, 1990 - Am Heart Assoc
… Tesfamariam B, Halpern W: Modulation of adrenergic responses in pressurized resistance
arteries by flow. Am J Physiol 1987;253:H-1112-H-1119 39. Diederich D, Yang Z, Buhler FR,…
arteries by flow. Am J Physiol 1987;253:H-1112-H-1119 39. Diederich D, Yang Z, Buhler FR,…
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines
…, R Fagard, C Farsang, AM Heagerty, W Kiowski… - J Hypertens, 2003 - journals.lww.com
• These guidelines are a concise summary of the more extensive ones prepared by the Expert
Committee appointed by the European Society of Hypertension and the European Society …
Committee appointed by the European Society of Hypertension and the European Society …
Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
W Kiowski, J Kim, E Oechslin, G Sütsch, P Hunziker… - The Lancet, 1995 - Elsevier
Heart failure is commonly associated with high plasma concentrations of endothelin-1, a
powerful vasoconstrictor produced by endothelium. The role of endogenously released …
powerful vasoconstrictor produced by endothelium. The role of endogenously released …
Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial
…, D Burckhardt, M Zuber, W Kiowski… - Jama, 2007 - jamanetwork.com
ContextThe effect of a percutaneous coronary intervention (PCI) on the long-term prognosis
of patients with silent ischemia after a myocardial infarction (MI) is not known.ObjectiveTo …
of patients with silent ischemia after a myocardial infarction (MI) is not known.ObjectiveTo …
Calcium antagonists in hypertension
FR Buhler, W Kiowski - Journal of Hypertension, 1987 - journals.lww.com
Calcium antagonists are potent arterial vasodilators with no long-term effect on sympathetic
reflex activity or sodium and volume retention. This favourable haemodynamic profile makes …
reflex activity or sodium and volume retention. This favourable haemodynamic profile makes …
Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide
…, H Schneider, KH Boedeker, W Kiowski… - European heart …, 1999 - academic.oup.com
Aims Glimepiride is a new sulfonylurea for diabetes treatment which is supposed to impact
less on extra-pancreatic ATP-dependent K + channels than the conventional drug …
less on extra-pancreatic ATP-dependent K + channels than the conventional drug …